Ngày 04/03/1988 | 02:04.

Vascular Grafts Solutions has announced receipt of marketing clearance from the US Food and Drug Administration (FDA) for the Viola, a new device for clampless proximal anastomosis in coronary artery bypass grafting (CABG).

Ngày 03/03/1988 | 08:57.

Innovative Cardiovascular Solutions (ICS) has announced the success of its first European clinical cases using the next generation of the Emblok embolic protection system in patients undergoing transcatheter aortic valve implantation (TAVI). The procedures were performed by Federico De Marco at IRCCS Policlinico San Donato, Milan, Italy.

Ngày 02/03/1988 | 10:14.

A US Food and Drug Administration (FDA) advisory panel has recommended against premarket approval of BD’s Lutonix 014 drug-coated balloon (DCB) for use in below-the-knee (BTK) arteries. In a meeting on 17 February, the majority of the FDA Cardiovascular Devices Panel concluded that the device was likely safe in BTK arteries, but not effective. The benefit-risk ratio also did not appear favourable for the Lutonix 014 DCB, it claimed.

Ngày 01/03/1988 | 11:19.

A secondary analysis of the COAPT trial, which sought to account for differences in the findings of COAPT and the Mitra-FR trial in patients with secondary mitral regurgitation (MR), has concluded that a divergence between the two studies over inclusion criteria relating to “proportionate and disproportionate” MR did not predict outcomes within the COAPT trial.

Ngày 25/02/1988 | 10:11.

After Shockwave Medical announced that its intravascular lithotripsy (IVL) technology received pre-market approval for the treatment of severely calcified coronary artery disease from the US Food and Drug Administration (FDA), Cardiovascular Newsspoke to Dean Kereiakes, president, The Christ Hospital Heart and Vascular Institute, professor of clinical medicine, The Ohio State University (Columbus, USA), and the co-principal investigator of the pivotal Disrupt CAD III study to discuss how IVL has the potential to revolutionise the treatment of problematic coronary calcium.

Ngày 24/02/1988 | 11:26.

Urgent action is needed to address the growing burden of heart failure and the impact of COVID-19 in the UK, according to a report issued this week by the Alliance for Heart Failure.

Ngày 22/02/1988 | 09:02.

Medtronic has voluntarily issued a global recall of its Valiant Navion thoracic stent graft system and informed physicians to immediately cease use of the device until further notice.

Ngày 20/02/1988 | 12:36.

Caption Health has announced the publication of a study in JAMA Cardiology assessing its artificial intelligence (AI) guidance software for cardiac ultrasound examinations. The study was the basis for the February 2020 authorisation of Caption Guidance through the US Food and Drug Administration’s (FDA) de novopathway. The Caption AI platform, which includes Caption Guidance and Caption Interpretation, is an AI-guided medical imaging acquisition software.

Ngày 19/02/1988 | 10:39.

Around 50% of patients who have been hospitalised with severe COVID-19 and have raised levels of troponin have heart damage, according to a study published in the European Heart Journal. The injury was detected by magnetic resonance imaging (MRI) scans at least a month after discharge and includes myocarditis, infarction, ischaemia and combinations of all three.

Ngày 04/02/1988 | 12:31.

The German Institute for Hospital Remuneration (InEK) has renewed the new examination and treatment methods (NUB) Status 1 designation of VasQ external support (Laminate Medical Technologies) for 2021.

Ngày 03/02/1988 | 12:31.

Cagent Vascular announced the results of its PRELUDE-BTK study at LINC 2021 (25–29 January, online). The PRELUDE-BTK study was a prospective, single-arm, multicentre feasibility study to show the safety and efficacy of serration angioplasty.

Ngày 01/02/1988 | 12:06.

Twelve-month results from the PRESTIGE below-the-knee (BTK) study have been presented as a late-breaking trial at LINC 2021(The Leipzig Interventional Course; 25–29 January, online). The objective of this clinical investigation has been to evaluate safety and performance outcomes of SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, for the treatment of long tibial occlusive lesions (TASC C and D) in patients with chronic limb-threatening ischaemia (CLTI).


  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389